In May 2022, the National Institute for Health and Care Excellence (NICE) released a landmark recommendation. NICE, which evaluates new drugs and medical technologies for the NHS, concluded that Sleepio – a digital treatment for insomnia – should be considered by GPs as an effective and cost-saving alternative to sleeping pills.
It meant that Sleepio, which uses evidence-based cognitive behavioural therapy (CBT) techniques for people experiencing insomnia, became the first digital therapeutic in the UK to receive the NICE stamp of approval.
